RxDoctor Payments DataLook up a doctor →

John Byrd, MD

Hematology · Cincinnati, OHNPI 1770599664

Payments from drug & device makers

$4,882,547in general payments, 2019–2025

Across 340 payments — averaging $14,360 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3M
  • Pharmacyclics LLC, An Abbvie Company$896K
  • Bristol Myers Squibb$461K
  • Acerta Pharma LLC$249K
  • AbbVie$185K
  • Gilead$25K
  • plus $53K from 7 others
$1,371in research payments, 2019–2025

Across 2 payments — averaging $685.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,882,547 in reported general payments places this provider in the 90th percentile of 84 hematology providers in Ohio.

See all hematology providers in Ohio

Medicare billing

Part B allowed, 2024
$47,941
Medicare patients
199
Services billed
646

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →